Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

Anna C. Ferrari, Joshi J. Alumkal, Mark N. Stein, Mary Ellen Taplin, James Babb, Ethan S. Barnett, Alejandro Gomez-Pinillos, Xiaomei Liu, Dirk Moore, Robert DiPaola, Tomasz M. Beer

    Research output: Contribution to journalComment/debate

    Abstract

    In the original version of this article (1), a sentence was missing in the Results section of the Abstract. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets this error.

    Original languageEnglish (US)
    Number of pages1
    JournalClinical Cancer Research
    Volume25
    Issue number8
    DOIs
    StatePublished - Apr 15 2019

    ASJC Scopus subject areas

    • Oncology
    • Cancer Research

    Fingerprint Dive into the research topics of 'Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)'. Together they form a unique fingerprint.

  • Cite this